Alkermes Reports Strong Phase 2 Data for Narcolepsy Drug
DUBLIN, April 16, 2026 Alkermes plc has announced new data from its Vibrance-1 Phase 2 clinical study of alixorexton,...
Phase 2
Advertisement
MAIA Activates U.S. Site for Phase 2 Lung Cancer Trial
CHICAGO, April 16, 2026 MAIA Biotechnology, Inc. has announced the activation of its first U.S. clinical site for the...
XellSmart Advances Phase 2 Parkinson’s Cell Therapy Trial
Suzhou, China | April 14, 2026 XellSmart has announced the initiation of a multicenter Phase II clinical trial evaluating...
Hoth HT-001 Meets Endpoint, Expands Phase 2 Trial in EU
NEW YORK, USA — April 1, 2026 Hoth Therapeutics, Inc. announced that its investigational therapy HT-001 has successfully met...
Anixa Advances Breast Cancer Vaccine to Phase 2 Trial
SAN JOSE, Calif., USA — April 1, 2026 In a significant advancement in cancer immunotherapy and clinical-stage biotechnology innovation,...
Advertisement
